{"id":"W2417794644","doi":"10.1155/2001/645147","title":"Canadian Expert Panel Recommendations on the Management of CNS Symptoms Related to Efavirenz","year":2001,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Alberta Hip and Knee Clinic; University of Calgary","funders":"Pfizer Canada; Department of Medicine, University of Toronto; McGill University; F. Hoffmann-La Roche; Agouron Pharmaceuticals; DuPont; Abbott Laboratories; GlaxoSmithKline; Merck; University of Toronto; Pfizer; University of Alberta; Bristol-Myers Squibb","keywords":"Efavirenz; Medicine; Discontinuation; Adverse effect; Intensive care medicine; Rash; Antiretroviral therapy; Human immunodeficiency virus (HIV); Psychiatry; Viral load; Family medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01379782,0.001198955,0.001364974,0.004375402,0.003245474,0.001965837,0.007272755,0.008617532,0.01082758],"category_scores_gemma":[0.02618192,0.0008139668,0.003024687,0.004632846,0.001595821,0.001038547,0.001157366,0.00695697,0.003405866],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01537186,"about_ca_system_score_gemma":0.07309636,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5262723,"about_ca_topic_score_gemma":0.6536967,"domain_scores_codex":[0.9883366,0.002665028,0.001476095,0.0003864463,0.006064014,0.001071683],"domain_scores_gemma":[0.9616961,0.003503053,0.001221553,0.0003951662,0.02993146,0.003252614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007448922,0.00006719818,0.0009100089,0.001210465,0.00004018044,0.0004692563,0.0002200328,0.000358665,0.0003024978,0.001972581,0.9202967,0.0740779],"study_design_scores_gemma":[0.0001568153,0.00004157848,0.005211033,0.003900442,0.0001604002,0.0004626996,0.0002412155,0.0002919565,0.0001958523,0.001463774,0.9878041,0.00007019149],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003291442,0.1506609,0.01323014,0.5138359,0.02945316,0.007808185,0.01009491,0.0006360271,0.2709894],"genre_scores_gemma":[0.04936633,0.2640592,0.2033337,0.2671583,0.01205271,0.008320723,0.02272062,0.0003278676,0.1726605],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9846281,"threshold_uncertainty_score":0.9530352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00961502112865052,"score_gpt":0.2461477707293705,"score_spread":0.23653274960072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}